Clinical trial
An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With…
NCT00383188 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00383188 |
|---|---|
| Title | An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis |
| Official title | A 12-WEEK, PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF PH 797804, ADMINISTERED ORALLY ONCE DAILY IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | placebo, PH-797804 |
| Enrollment | 305 |
| Start date | Dec 15, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 16, 2008 |
| First posted | Oct 2, 2006 |
| Last update posted | Aug 20, 2021 |
| Countries | Australia, Brazil, Chile, Czechia, Estonia, India, Peru, Poland, Russia, South Africa, South Korea, Spain |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: